Pages that link to "Q37381183"

The following pages link to Fabien Guidez (Q37381183):

Displaying 34 items.

• The histone deacetylase 9 gene encodes multiple protein isoforms (Q24294872) (← links)
• Regulation of Hoxb2 by APL-associated PLZF protein (Q24304801) (← links)
• Amino-terminal protein-protein interaction motif (POZ-domain) is responsible for activities of the promyelocytic leukemia zinc finger-retinoic acid receptor-alpha fusion protein (Q24308811) (← links)
• PLZF-RAR alpha fusion proteins generated from the variant t(11;17)(q23;q21) translocation in acute promyelocytic leukemia inhibit ligand-dependent transactivation of wild-type retinoic acid receptors (Q24563942) (← links)
• Colocalization and heteromerization between the two human oncogene POZ/zinc finger proteins, LAZ3 (BCL6) and PLZF (Q28200033) (← links)
• Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARalpha underlie molecular pathogenesis and treatment of acute promyelocytic leukemia (Q28266768) (← links)
• Histone acetyltransferase activity of p300 is required for transcriptional repression by the promyelocytic leukemia zinc finger protein. (Q33863009) (← links)
• A RP-UFLC Assay for Protein Tyrosine Phosphatases: Focus on Protein Tyrosine Phosphatase Non-Receptor Type 2 (PTPN2). (Q35682010) (← links)
• GEP analysis validates high risk MDS and acute myeloid leukemia post MDS mice models and highlights novel dysregulated pathways (Q36507980) (← links)
• The epigenetic regulator PLZF represses L1 retrotransposition in germ and progenitor cells (Q37261517) (← links)
• Acute promyelocytic leukemia: a paradigm for differentiation therapy (Q37715816) (← links)
• HDAC4 as a potential therapeutic target in neurodegenerative diseases: a summary of recent achievements (Q38373328) (← links)
• Differential utilization of Ras signaling pathways by macrophage colony-stimulating factor (CSF) and granulocyte-macrophage CSF receptors during macrophage differentiation (Q39575154) (← links)
• Acute promyelocytic leukemia cell line AP-1060 established as a cytokine-dependent culture from a patient clinically resistant to all-trans retinoic acid and arsenic trioxide (Q40561431) (← links)
• An acetyltransferase assay for CREB-binding protein based on reverse phase-ultra-fast liquid chromatography of fluorescent histone H3 peptides (Q40811060) (← links)
• Juvenile myelomonocytic leukemia displays mutations in components of the RAS pathway and the PRC2 network. (Q40957134) (← links)
• The macrosialin promoter directs high levels of transcriptional activity in macrophages dependent on combinatorial interactions between PU.1 and c-Jun (Q41056192) (← links)
• The PML-RAR alpha gene product of the t(15;17) translocation inhibits retinoic acid-induced granulocytic differentiation and mediated transactivation in human myeloid cells (Q41489537) (← links)
• Retinoic acid inhibits the expression of cytidine deaminase linked to the differentiation of the human leukemic cell line HL-60. (Q41671315) (← links)
• Post transcriptional control of the epigenetic stem cell regulator PLZF by sirtuin and HDAC deacetylases (Q42040126) (← links)
• Resistance to all-trans retinoic acid (ATRA) therapy in relapsing acute promyelocytic leukemia: study of in vitro ATRA sensitivity and cellular retinoic acid binding protein levels in leukemic cells (Q42289102) (← links)
• 1 alpha,25-dihydroxyvitamin D3 transrepresses retinoic acid transcriptional activity via vitamin D receptor in myeloid cells (Q45000538) (← links)
• Benzodithiophenes potentiate differentiation of acute promyelocytic leukemia cells by lowering the threshold for ligand-mediated corepressor/coactivator exchange with retinoic acid receptor alpha and enhancing changes in all-trans-retinoic acid-regu (Q46685705) (← links)
• Rexinoid-triggered differentiation and tumor-selective apoptosis of acute myeloid leukemia by protein kinase A-mediated desubordination of retinoid X receptor (Q46735203) (← links)
• Retinoblastoma protein and the leukemia-associated PLZF transcription factor interact to repress target gene promoters. (Q53539317) (← links)
• Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL. (Q54147247) (← links)
• Lithium chloride antileukemic activity in acute promyelocytic leukemia is GSK-3 and MEK/ERK dependent. (Q54263446) (← links)
• Mechanism of action of retinoids in a new therapeutic approach to acute promyelocytic leukemia (Q64051543) (← links)
• [Nuclear receptors and ontogenesis of the hematopoietic tissue] (Q70907263) (← links)
• Hematopoietic growth factor expression and ATRA sensitivity in acute promyelocytic blast cells (Q72454788) (← links)
• Poor response to all-trans retinoic acid therapy in a t(11;17) PLZF/RAR alpha patient (Q72775936) (← links)
• Recruitment of the nuclear receptor corepressor N-CoR by the TEL moiety of the childhood leukemia-associated TEL-AML1 oncoprotein (Q72992367) (← links)
• Synthesis and evaluation of a potent and selective cell-permeable p300 histone acetyltransferase inhibitor (Q81582287) (← links)
• [Retrotransposons: selfish DNA or active epigenetic players in somatic cells?] (Q87385657) (← links)